Clinical Trial Update: A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated glutamine for improving intestinal permeability in individuals with functional dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: David J. Cangemi | Conditions: Functional Dyspepsia | Phase 1, Phase 2 | Status: COMPLETED